Ketanrift
Ketanrift Brand names, Ketanrift Analogs
- 7HP
- Adenock
- Ailural
- Allo-Puren
- Allopur
- Allopurinol Sodium
- Allopurinolum [Inn-Latin]
- Allozym
- Allural
- Aloprim
- Alopurinol [Inn-Spanish]
- Aloral
- Alositol
- Aluline
- Anoprolin
- Anzief
- Apo-Allopurinol
- Apulonga
- Apurin
- Apurol
- Atisuril
- Bleminol
- Bloxanth
- Caplenal
- Cellidrin
- Cosuric
- Dabrosin
- Dabroson
- Dura Al
- Embarin
- Epidropal
- Epuric
- Foligan
- Geapur
- Gichtex
- Gotax
- HPP
- Hamarin
- Hexanuret
- Ketanrift
- Ketobun-A
- Ledopur
- Lopurin
- Lysuron
- Milurit
- Miniplanor
- Monarch
- Nektrohan
- Progout
- Purinol
- Remid
- Riball
- Sigapurol
- Suspendol
- Takanarumin
- Urbol
- Uricemil
- Uriprim
- Uripurinol
- Uritas
- Urobenyl
- Urolit
- Urosin
- Urtias
- Urtias 100
- Xanturat
- Zyloprim
- Zyloric
Ketanrift Brand Names Mixture
- No information avaliable
Ketanrift Chemical_Formula
C5H4N4O
Ketanrift RX_link
http://www.rxlist.com/cgi/generic/allopur.htm
Ketanrift fda sheet
Ketanrift msds (material safety sheet)
Ketanrift Synthesis Reference
Robins, J. Am. Chem. So. 78, 784 (1956)
Ketanrift Molecular Weight
136.112 g/mol
Ketanrift Melting Point
350 oC
Ketanrift H2O Solubility
569 mg/L
Ketanrift State
Solid
Ketanrift LogP
-0.177
Ketanrift Dosage Forms
Tablet for oral administration (100mg, 200mg and 300mg); Injection
Ketanrift Indication
For the treatment of hyperuricemia associated with primary or secondary gout.
Ketanrift Pharmacology
Allopurinol, a structural analog of the natural purine base hypoxanthine, is used to prevent gout and renal calculi due to either uric acid or calcium oxalate and to treat uric acid nephropathy, hyperuricemia, and some solid tumors.
Ketanrift Absorption
Approximately 90% absorbed from the gastrointestinal tract.
Ketanrift side effects and Toxicity
LD50=214 mg/kg (in mice)
Ketanrift Patient Information
Patients should be informed of the following:
- 1. They should be cautioned to discontinue allopurinol and to consult their physician immediately at the first sign of a skin rash, painful urination, blood in the urine, irritation of the eyes, or swelling of the lips or mouth.
- 2. They should be reminded to continue drug therapy prescribed for gouty attacks since optimal benefit of allopurinol may be delayed for two to six weeks.
- 3. They should be encouraged to increase fluid intake during therapy to prevent renal stones.
- 4. If a single dose of allopurinol is occasionally forgotten, there is no need to double the dose at the next scheduled time.
- 5. There may be certain risks associated with the concomitant use of allopurinol and dicumarol, sulfinpyrazone, mercaptopurine, azathioprine, ampicillin, amoxicillin and thiazide diuretics, and they should follow the instructions of their physician.
- 6. Due to the occasional occurrence of drowsiness, patients should take precautions when engaging in activities where alertness is mandatory.
- 7. Patients may wish to take allopurinol after meals to minimize gastric irritation.
Ketanrift Organisms Affected
Humans and other mammals
